세계의 초붕괴제 시장 보고서(2025년)
Superdisintegrants Global Market Report 2025
상품코드 : 1720899
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

초붕괴제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.3%로 14억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 경구 고형제에 대한 수요 증가, 만성 질환의 유병률 증가, 의약품 제조 확대, 효과적인 약물 전달 솔루션에 대한 필요성 증가로 인한 것입니다. 예측기간 중 주요 동향으로는 제조에 있어서의 기술의 통합, 공가공 부형제의 발전, 천연과 생분해성 초붕괴제로의 시프트, 혁신적인 약물전달 시스템의 개발, 부형제 제조업체와 제약회사의 제휴 강화 등을 들 수 있습니다.

일반 의약품 생산 증가는 초붕괴제 시장의 성장을 가속할 것으로 예측됩니다. 제네릭 의약품은 활성 성분, 용량, 강도, 투여 경로, 품질 및 성능은 선발 의약품과 동일하지만 일반적으로 저렴합니다. 제네릭 의약품의 생산이 증가하고 있는 배경으로는 저렴한 의약품에 대한 수요가 증가하고, 브랜드 의약품의 특허 만료, 헬스케어 비용의 삭감을 목적으로 한 정부의 대처 등이 있습니다. 초붕괴제는 정제의 붕괴 및 용출을 촉진하고, 약물의 신속한 방출, 생체이용률 향상, 환자의 컴플라이언스 향상으로 이어지는 등 제네릭 의약품의 제제에 있어서 중요한 역할을 하고 있습니다. 예를 들어, 2023년 1월 미국 정부기관인 식품의약국(FDA)은 2022년에는 미국 내 처방전의 약 91%가 제네릭 의약품으로 채워졌으며 지금까지 3만 2,000개 이상의 제네릭 의약품이 FDA에 의해 승인되었다고 보고했습니다. 그 결과, 제네릭 의약품의 생산이 증가하여 초붕괴제 시장의 확대에 기여하고 있습니다.

초붕괴제 시장의 주요 기업은 의약품의 제형 효율을 높이고, 정제의 붕괴를 촉진하고, 의약품 용도에서 환자의 컴플라이언스를 개선하기 위해 다기능 붕괴제와 같은 혁신적인 솔루션에 주력하고 있습니다. 다기능 붕괴제는 정제의 제제 효율과 약물 방출을 최적화하기 위해 붕괴성, 결합성, 유동성을 높이는 특성을 겸비한 선진적 부형제입니다. 예를 들어, 2023년 6월 미국의 화학 회사인 Ashland Inc.는 제약 제조 과정에서 정제 붕해, 분말 유동성 및 윤활성을 개선하도록 설계된 공동 가공 다기능 직접 압축 초붕해제인 Polyplasdone Plus를 선보였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Superdisintegrants are pharmaceutical excipients specifically formulated to accelerate the disintegration of tablets or capsules, enabling faster release and absorption of the active pharmaceutical ingredient (API) in the body. They are essential for enhancing drug bioavailability and ensuring efficacy, particularly in orally administered medications.

The primary categories of superdisintegrants include natural, synthetic, and other types. Natural superdisintegrants are plant-based or naturally derived substances that aid in the breakdown of tablets within the gastrointestinal tract, improving drug dissolution and absorption. These excipients are used in various formulations, such as tablets and capsules, and play a vital role in treating a range of therapeutic areas, including gastrointestinal diseases, neurological disorders, oncology, infectious diseases, cardiovascular conditions, and hematological diseases.

The superdisintegrants market research report is one of a series of new reports from The Business Research Company that provides superdisintegrants market statistics, including the superdisintegrants industry global market size, regional shares, competitors with the superdisintegrants market share, detailed superdisintegrants market segments, market trends, and opportunities, and any further data you may need to thrive in the superdisintegrants industry. This superdisintegrants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The superdisintegrants market size has grown strongly in recent years. It will grow from $1.09 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be credited to the increasing prevalence of chronic and lifestyle-related diseases, the expansion of the global pharmaceutical industry, the rising demand for orally disintegrating tablets (ODTs), the growing geriatric and pediatric populations, and the heightened focus on enhancing drug bioavailability.

The superdisintegrants market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period can be credited to the increasing demand for oral solid dosage forms, the rising prevalence of chronic diseases, the expansion of pharmaceutical manufacturing, and the growing need for effective drug delivery solutions. Key trends in the forecast period include the integration of technology in manufacturing, advancements in co-processed excipients, a shift toward natural and biodegradable superdisintegrants, the development of innovative drug-delivery systems, and enhanced collaboration between excipient manufacturers and pharmaceutical companies.

The increasing production of generic drugs is expected to drive the growth of the superdisintegrants market. Generic drugs contain the same active ingredients, dosage, strength, route of administration, quality, and performance as brand-name drugs but are generally available at a lower cost. The rising production of generic drugs is fueled by the growing demand for affordable medications, the expiration of patents for branded drugs, and government initiatives aimed at reducing healthcare costs. Superdisintegrants play a crucial role in generic drug formulations by enhancing tablet disintegration and dissolution, leading to faster drug release, improved bioavailability, and better patient compliance. For example, in January 2023, the Food and Drug Administration (FDA), a US-based government agency, reported that in 2022, approximately 91% of prescriptions in the United States were filled with generic drugs, with over 32,000 generic medications having been approved by the FDA to date. As a result, the increasing production of generic drugs is contributing to the expansion of the superdisintegrants market.

Key companies in the superdisintegrants market are focusing on innovative solutions, such as multifunctional disintegrants, to enhance drug formulation efficiency, accelerate tablet disintegration, and improve patient compliance in pharmaceutical applications. Multifunctional disintegrants are advanced excipients that combine disintegration, binding, and flow-enhancing properties to optimize tablet formulation efficiency and drug release. For instance, in June 2023, Ashland Inc., a US-based chemicals company, introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant designed to improve tablet disintegration, powder flow, and lubrication during pharmaceutical manufacturing. This innovation streamlines production by eliminating two manufacturing steps, enhancing tablet hardness, and supporting high-speed and continuous manufacturing processes.

In April 2023, Ingredion Inc., a US-based food company, acquired Amishi Drugs & Chemicals Private Limited for an undisclosed amount. Through this acquisition, Ingredion aims to expand its portfolio of specialty pharmaceutical products, strengthen its expertise in functional excipients, establish a stronger presence in the rapidly growing Indian pharmaceutical market, and support global exports with high-quality, pharma-grade ingredients. Amishi Drugs & Chemicals Private Limited is an India-based company specializing in the production of superdisintegrants for enhanced tablet disintegration and drug formulation.

Major players in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., and JH Nanhang Life Sciences Co. Ltd.

North America was the largest region in the superdisintegrants market in 2024. The regions covered in superdisintegrants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the superdisintegrants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The superdisintegrants market consists of sales of co-processed superdisintegrants, polymer-based superdisintegrants, and cross-linked superdisintegrants. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Superdisintegrants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on superdisintegrants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for superdisintegrants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The superdisintegrants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Superdisintegrants Market Characteristics

3. Superdisintegrants Market Trends And Strategies

4. Superdisintegrants Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Superdisintegrants Growth Analysis And Strategic Analysis Framework

6. Superdisintegrants Market Segmentation

7. Superdisintegrants Market Regional And Country Analysis

8. Asia-Pacific Superdisintegrants Market

9. China Superdisintegrants Market

10. India Superdisintegrants Market

11. Japan Superdisintegrants Market

12. Australia Superdisintegrants Market

13. Indonesia Superdisintegrants Market

14. South Korea Superdisintegrants Market

15. Western Europe Superdisintegrants Market

16. UK Superdisintegrants Market

17. Germany Superdisintegrants Market

18. France Superdisintegrants Market

19. Italy Superdisintegrants Market

20. Spain Superdisintegrants Market

21. Eastern Europe Superdisintegrants Market

22. Russia Superdisintegrants Market

23. North America Superdisintegrants Market

24. USA Superdisintegrants Market

25. Canada Superdisintegrants Market

26. South America Superdisintegrants Market

27. Brazil Superdisintegrants Market

28. Middle East Superdisintegrants Market

29. Africa Superdisintegrants Market

30. Superdisintegrants Market Competitive Landscape And Company Profiles

31. Superdisintegrants Market Other Major And Innovative Companies

32. Global Superdisintegrants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Superdisintegrants Market

34. Recent Developments In The Superdisintegrants Market

35. Superdisintegrants Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기